The SIF binding element confers sis/PDGF inducibility onto the c‐fos promoter. BJ Wagner, TE Hayes, CJ Hoban, BH Cochran The EMBO journal 9 (13), 4477-4484, 1990 | 733 | 1990 |
Epinephrine-induced changes in the distribution of lymphocyte subsets in peripheral blood of humans. B Crary, SL Hauser, M Borysenko, I Kutz, C Hoban, KA Ault, HL Weiner, ... Journal of immunology (Baltimore, Md.: 1950) 131 (3), 1178-1181, 1983 | 354 | 1983 |
The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis B Cannella, CJ Hoban, YL Gao, R Garcia-Arenas, D Lawson, ... Proceedings of the National Academy of Sciences 95 (17), 10100-10105, 1998 | 192 | 1998 |
Immunohistochemical staining of human brain with monoclonal antibodies that identify lymphocytes, monocytes, and the Ia antigen SL Hauser, AK Bhan, FH Gilles, CJ Hoban, EL Reinherz, SF Schlossman, ... Journal of neuroimmunology 5 (2), 197-205, 1983 | 174 | 1983 |
Immunoregulatory T‐cells and lymphocytotoxic antibodies in active multiple sclerosis: Weekly analysis over a six‐month period SL Hauser, EL Reinherz, CJ Hoban, SF Schlossman, HL Weiner Annals of Neurology: Official Journal of the American Neurological …, 1983 | 103 | 1983 |
CSF cells in multiple sclerosis: Monoclonal antibody analysis and relationship to peripheral blood T‐cell subsets SL Hauser, EL Reinherz, CJ Hoban, SF Schlossman, HL Weiner Neurology 33 (5), 575-575, 1983 | 97 | 1983 |
Neuregulin in neuron/glial interactions in the central nervous system: GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion, and enhances … MA Marchionni, C Hoban, R Garcia-Arenas, D Lawson, E Happel, ... The Functional Roles of Glial Cells in Health and Disease: Dialogue between …, 1999 | 67 | 1999 |
Platelet‐derived growth factor stimulates rapid polyphosphoinositide breakdown in fetal human fibroblasts SHW Chu, CJ Hoban, AJ Owen, RP Geyer Journal of cellular physiology 124 (3), 391-396, 1985 | 57 | 1985 |
Neuregulins as potential drugs for neurological disorders MA Marchionni, CJ Kirk, IJ Isaacs, CJ Hoban, NK Mahanthappa, ES Anton, ... Cold Spring Harbor symposia on quantitative biology 61, 459-472, 1996 | 31 | 1996 |
Prioritization in comparative effectiveness research: the CANCERGEN Experience R Thariani, W Wong, JJ Carlson, L Garrison, S Ramsey, PA Deverka, ... Medical care 50 (5), 388-393, 2012 | 22 | 2012 |
Increased IgG secretion by unstimulated mononuclear cells in active multiple sclerosis and functional assessment of the T8 subset SL Hauser, KA Ault, D Johnson, C Hoban, HL Weiner Clinical immunology and immunopathology 37 (3), 312-323, 1985 | 9 | 1985 |
Increased spontaneous IgG production by cultured mononuclear cells in multiple sclerosis SL Hauser, CJ Hoban, EL Reinherz, HL Weiner Neurology 33 (Suppl 2), 180, 1983 | 5 | 1983 |
From the lab to the clinic: integration of pharmacogenics into clinical development CJ Hoban Pharmacogenomics 3 (4), 429-436, 2002 | 4 | 2002 |
The multiple myeloma research foundation (MMRF) commpassSM study: A longitudinal study in newly-diagnosed multiple myeloma patients to assess genomic profiles, immunophenotypes … MN Needle, B Harrison, C Hoban, PG Kidd, S Jewell, T Monroe, JJ Keats, ... Blood 120 (21), 3980, 2012 | 3 | 2012 |
SWOG Cooperative Group biorepository resource: access for scientific research studies CJ Hoban, W Franklin, KJ Kopecky, LH Baker Clinical Cancer Research 17 (16), 5239-5246, 2011 | 3 | 2011 |
Recent advances in preclinical drug development in multiple sclerosis CJ Hoban Expert Opinion on Therapeutic Patents 8 (7), 831-854, 1998 | 2 | 1998 |
Neuregulin in neuron/glial interactions in the central nervous system MA Marehionni, B Cannella, C Hoban GGF2 diminishes autoimmune demyelination, promotes oligodendro-cyte …, 1999 | 1 | 1999 |
The MMRF CoMMpassSM Study: A prospective, longitudinal, multicenter observational study in newly diagnosed multiple myeloma patients to assess the relationship between patient … CJ Hoban, P Kidd, S Jewell, T Monroe, S Khoo, D Rohrer, J Levy, ... Cancer Research 72 (8_Supplement), 4561-4561, 2012 | | 2012 |
PCN82 RESEARCH PRIORITIZATION FOR PROSPECTIVE COMPARATIVE EFFECTIVENESS RESEARCH (CER) IN CANCER GENOMICS D Veenstra, R Thariani, JJ Carlson, L Garrison, P Mohr, P Deverka, ... Value in Health 7 (13), A266, 2010 | | 2010 |
Activation index of IGF-IR in sarcoma subtypes C Hoban, D Thomas, D Lev, R Pollock, L Baker Cancer Research 68 (9_Supplement), 2192-2192, 2008 | | 2008 |